SCHEMBL8637873

SCHEMBL8637873

Cc1ccc(-n2nc(C(F)(F)F)c(-c3ccccc3)c2-c2ccc(S(N)(=O)=O)cc2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 17/20 0.69
PTGS1 P23219 13/20 0.69
PDPK1 O15530 3/20 0.56
CYP2C9 P11712 2/20 0.56
PTGES O14684 1/20 0.56
HDAC3 O15379 1/20 0.56
CA12 O43570 1/20 0.56
PDE5A O76074 1/20 0.56
ABCB11 O95342 1/20 0.56
MT-CO2 P00403 1/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
LMNA P02545 1/20 0.56
CA3 P07451 1/20 0.56
CYP3A4 P08684 1/20 0.56
ALOX5 P09917 1/20 0.56
ADORA3 P0DMS8 1/20 0.56
CYP2D6 P10635 1/20 0.56
ADRB3 P13945 1/20 0.56
ALOX15 P16050 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8637124 0.97 PTGS2 (0.64) PTGS2PTGS1PDPK1CYP2C9PTGES
SCHEMBL8765415 0.96 PTGS2 (0.67) PTGS2PTGS1PDPK1CYP2C9PTGES
SCHEMBL27475175 0.93 PTGS2 (0.78) PTGS2PTGS1PDPK1
SCHEMBL8764637 0.92 PTGS2 (0.72) PTGS2PTGS1PDPK1
SCHEMBL8631360 0.90 PTGS2 (0.73) PTGS2PTGS1PDPK1CA1CA2
SCHEMBL8631459 0.90 PTGS2 (0.70) PTGS2PTGS1PDPK1
SCHEMBL8607041 0.90 PTGS2 (0.70) PTGS2PTGS1PDPK1CA1CA2
SCHEMBL8636842 0.90 PTGS2 (0.70) PTGS2PTGS1PDPK1CYP2C9
Dimethylamine SCHEMBL8635160 0.90 PTGS2 (0.67) PTGS2PTGS1PDPK1
SCHEMBL8661740 0.90 PTGS2 (0.56) PTGS2PTGS1CYP2C9ALOX5CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0731794-B1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1997-08-06 EP claimed
US-5639777-A 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders G.D. SEARLE & CO. (US) 1997-06-17 US claimed
EP-0731794-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1996-09-18 EP claimed
WO-1995015317-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS G.D. SEARLE & CO. (US) 1995-06-08 WO claimed
EP-0830133-A1 THERAPEUTIC COMPOSITION FOR ARTHRITIS Takeda Chemical Industries, Ltd. (JP) 1998-03-25 EP disclosed
EP-0731794-B1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1997-08-06 EP disclosed
US-5639777-A 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders G.D. SEARLE & CO. (US) 1997-06-17 US disclosed
WO-1996033717-A1 THERAPEUTIC COMPOSITION FOR ARTHRITIS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-10-31 WO disclosed
EP-0731794-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1996-09-18 EP disclosed
WO-1995015317-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS G.D. SEARLE & CO. (US) 1995-06-08 WO disclosed